Belpointe Asset Management LLC Inovio Pharmaceuticals, Inc. Transaction History

Belpointe Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.79 - $1.91 $1,373 - $3,319	-1,738 Reduced 75.11%	576 $0
Q4 2022 Feb 08, 2023	BUY	$1.41 - $2.5 $3,262 - $5,785	2,314 New	2,314 $3,000
Q3 2020 Nov 13, 2020	SELL	$9.57 - $27.05 $64,109 - $181,207	-6,699 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$7.14 - $31.69 $47,830 - $212,291	6,699 New	6,699 $180,000
Q1 2018 Aug 06, 2018	SELL	$4.05 - $5.69 $64,800 - $91,040	-16,000 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$4.13 - $6.68 $31,569 - $51,061	-7,644 Reduced 32.33%	16,000 $66,000
Q3 2017 Nov 16, 2017	BUY	$5.36 - $6.37 $126,731 - $150,612	23,644	23,644 $150,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $524M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.